Who is sponsoring NCT05889000?

NCT05889000 is sponsored by Kazan State Medical University.

What drugs are being tested in NCT05889000?

Interventions in NCT05889000: questionnaire responses.

What condition does NCT05889000 study?

NCT05889000 studies Pelvic Congestion Syndrome.

Is NCT05889000 still recruiting?

NCT05889000 is currently completed. Last updated 5 June 2023.

Last reviewed 2023-06-05 · How we verify

NCT05889000

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality of Life Questionnaire and Disease Severity Scale

Completed Last updated 5 June 2023

What this trial tests

trial testing questionnaire responses in Pelvic Congestion Syndrome in 397 participants. Completed in 10 January 2022.

Timeline

10 January 2018

Primary endpoint
31 December 2020

10 January 2022

Quick facts

Lead sponsor	Kazan State Medical University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	397
Start date	10 January 2018
Primary completion	31 December 2020
Estimated completion	10 January 2022
Sites	1 location across Russia

Drugs / interventions tested

questionnaire responses

Conditions studied

Pelvic Congestion Syndrome — all drugs for Pelvic Congestion Syndrome →

Sponsor

Kazan State Medical University

Who can join

Adults 18 to 70, female only, with Pelvic Congestion Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are currently no specific validated patient-centric tools for the clinical evaluation of patients with chronic pelvic venous disorders (CPVD). The study involves the development and validation of a questionnaire for the quality of life and a scale of disease severity for a patient with pelvic venous disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pelvic Congestion Syndrome

Currently open trials in the same condition.

NCT06560294 — Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome · NA · recruiting

Other Kazan State Medical University trials

Trials by the same sponsor.

NCT05309499 — An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05889000 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kazan State Medical University
Last refreshed: 5 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05889000.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing